Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Papasozomenos, S.C.; * | Papasozomenos, T.
Affiliations: Department of Pathology and Laboratory Medicine, The University of Texas-Houston Medical School, Houston, TX 77030, USA
Correspondence: [*] Sozos Ch. Papasozomenos, M.D., Department of Pathology and Laboratory Medicine, The University of Texas-Houston Medical School, 6431 Fannin, Houston, TX 77030, USA, Tel: +1 713 500 5340; Fax: +1 713 500 0730; E-mail: papas@casper.med.uth.tmc.edu.
Abstract: We have previously shown that heat shock induces rapid dephosphorylation of τ in both female and male rats followed by hyperphosphorylation only in female rats (J Neurochem 66 (1996), 1140–1149). We have also shown that the heat shock-induced hyperphos-phorylation of τ is estrogen-independent in female rats and prevented by androgens in male rats (Proc Natl Acad Sci USA 94 (1997), 6612–6617). To investigate whether androgens could prevent the hyperphosphorylation of τ also in female rats, twenty-three 2- to 3-month-old Sprague-Dawley rats were ovariectomized and given daily subcutaneous injections of 1 mg/250 g of testosterone propionate for 3–5 weeks. Immunoblots of SDS cerebral extracts were analysed qualitatively using the peroxidase-antiperoxidase technique and phosphate-dependent and -independent anti-τ antibodies, and quantitatively using Tau-1 and 125I-labeled protein A. We have found that while at 0 h after heat shock τ was dephosphorylated, at 3 h and 6 h after heat shock τ was not hyperphosphorylated, as would be the case in non-androgen-treated female rats (ref. above). In addition, τ became dephosphorylated in non-heat-shocked control rats. Because τ is abnormally hyperphosphorylated in Alzheimer’s disease, the possibility of using combined estrogen/androgen replacement therapy in postmenopausal women as a preventive measure against Alzheimer’s disease should be investigated.
DOI: 10.3233/JAD-1999-1302
Journal: Journal of Alzheimer's Disease, vol. 1, no. 3, pp. 147-153, 1999
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl